Cargando…
A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs
The extent of susceptibility towards miltefosine (Mil), amphotericin B (AmpB), and paromomycin (Paro) was measured among 19 clinical isolates of Leishmania donovani (LD). Thirteen of these clinical isolates were reported to exhibit low susceptibility towards sodium stibogluconate (SSG-R), while six...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667613/ https://www.ncbi.nlm.nih.gov/pubmed/34912730 http://dx.doi.org/10.3389/fcimb.2021.768830 |
_version_ | 1784614415546449920 |
---|---|
author | Ghosh, Souradeepa Biswas, Souvik Mukherjee, Sandip Pal, Arijit Saxena, Aaditya Sundar, Shyam Dujardin, Jean-Claude Das, Soumen Roy, Syamal Mukhopadhyay, Rupkatha Mukherjee, Budhaditya |
author_facet | Ghosh, Souradeepa Biswas, Souvik Mukherjee, Sandip Pal, Arijit Saxena, Aaditya Sundar, Shyam Dujardin, Jean-Claude Das, Soumen Roy, Syamal Mukhopadhyay, Rupkatha Mukherjee, Budhaditya |
author_sort | Ghosh, Souradeepa |
collection | PubMed |
description | The extent of susceptibility towards miltefosine (Mil), amphotericin B (AmpB), and paromomycin (Paro) was measured among 19 clinical isolates of Leishmania donovani (LD). Thirteen of these clinical isolates were reported to exhibit low susceptibility towards sodium stibogluconate (SSG-R), while six of them were highly susceptible (SSG-S). The degree of clearance of amastigotes (EC50) for these predefined SSG-R- and SSG-S-infected macrophages was determined against Mil, AmpB, and Paro. Two out of the 13 SSG-R isolates (BHU575 and BHU814) showed low susceptibility towards all three drugs studied, while the rest of the 11 SSG-R isolates showed varying degrees of susceptibility either towards none or only towards individual drugs. Interestingly, all the SSG-S isolates showed high susceptibility towards Mil/AmpB/Paro. The total intracellular non-protein thiol content of the LD promastigotes, which have been previously reported to be positively co-related with EC50 towards SSG, was found to be independent from the degree of susceptibility towards Mil/AmpB/Paro. Impedance spectra analysis, which quantifies membrane resistance, revealed lower impedimetric values for all those isolates exhibiting low efficacy to Mil (Mil-R). Our analysis points out that while non-protein thiol content can be an attribute of SSG-R, lower impedimetric values can be linked with lower Mil susceptibility, although neither of these parameters seems to get influenced by the degree of susceptibility towards AmpB/Paro. Finally, a correlation analysis with established biological methods suggests that impedance spectral analysis can be used for the accurate determination of lower Mil susceptibility among LD isolates, which is further validated in the LD-infected in vivo hamster model. |
format | Online Article Text |
id | pubmed-8667613 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-86676132021-12-14 A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs Ghosh, Souradeepa Biswas, Souvik Mukherjee, Sandip Pal, Arijit Saxena, Aaditya Sundar, Shyam Dujardin, Jean-Claude Das, Soumen Roy, Syamal Mukhopadhyay, Rupkatha Mukherjee, Budhaditya Front Cell Infect Microbiol Cellular and Infection Microbiology The extent of susceptibility towards miltefosine (Mil), amphotericin B (AmpB), and paromomycin (Paro) was measured among 19 clinical isolates of Leishmania donovani (LD). Thirteen of these clinical isolates were reported to exhibit low susceptibility towards sodium stibogluconate (SSG-R), while six of them were highly susceptible (SSG-S). The degree of clearance of amastigotes (EC50) for these predefined SSG-R- and SSG-S-infected macrophages was determined against Mil, AmpB, and Paro. Two out of the 13 SSG-R isolates (BHU575 and BHU814) showed low susceptibility towards all three drugs studied, while the rest of the 11 SSG-R isolates showed varying degrees of susceptibility either towards none or only towards individual drugs. Interestingly, all the SSG-S isolates showed high susceptibility towards Mil/AmpB/Paro. The total intracellular non-protein thiol content of the LD promastigotes, which have been previously reported to be positively co-related with EC50 towards SSG, was found to be independent from the degree of susceptibility towards Mil/AmpB/Paro. Impedance spectra analysis, which quantifies membrane resistance, revealed lower impedimetric values for all those isolates exhibiting low efficacy to Mil (Mil-R). Our analysis points out that while non-protein thiol content can be an attribute of SSG-R, lower impedimetric values can be linked with lower Mil susceptibility, although neither of these parameters seems to get influenced by the degree of susceptibility towards AmpB/Paro. Finally, a correlation analysis with established biological methods suggests that impedance spectral analysis can be used for the accurate determination of lower Mil susceptibility among LD isolates, which is further validated in the LD-infected in vivo hamster model. Frontiers Media S.A. 2021-11-29 /pmc/articles/PMC8667613/ /pubmed/34912730 http://dx.doi.org/10.3389/fcimb.2021.768830 Text en Copyright © 2021 Ghosh, Biswas, Mukherjee, Pal, Saxena, Sundar, Dujardin, Das, Roy, Mukhopadhyay and Mukherjee https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Cellular and Infection Microbiology Ghosh, Souradeepa Biswas, Souvik Mukherjee, Sandip Pal, Arijit Saxena, Aaditya Sundar, Shyam Dujardin, Jean-Claude Das, Soumen Roy, Syamal Mukhopadhyay, Rupkatha Mukherjee, Budhaditya A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs |
title | A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs |
title_full | A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs |
title_fullStr | A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs |
title_full_unstemmed | A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs |
title_short | A Novel Bioimpedance-Based Detection of Miltefosine Susceptibility Among Clinical Leishmania donovani Isolates of the Indian Subcontinent Exhibiting Resistance to Multiple Drugs |
title_sort | novel bioimpedance-based detection of miltefosine susceptibility among clinical leishmania donovani isolates of the indian subcontinent exhibiting resistance to multiple drugs |
topic | Cellular and Infection Microbiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667613/ https://www.ncbi.nlm.nih.gov/pubmed/34912730 http://dx.doi.org/10.3389/fcimb.2021.768830 |
work_keys_str_mv | AT ghoshsouradeepa anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT biswassouvik anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT mukherjeesandip anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT palarijit anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT saxenaaaditya anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT sundarshyam anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT dujardinjeanclaude anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT dassoumen anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT roysyamal anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT mukhopadhyayrupkatha anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT mukherjeebudhaditya anovelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT ghoshsouradeepa novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT biswassouvik novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT mukherjeesandip novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT palarijit novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT saxenaaaditya novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT sundarshyam novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT dujardinjeanclaude novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT dassoumen novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT roysyamal novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT mukhopadhyayrupkatha novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs AT mukherjeebudhaditya novelbioimpedancebaseddetectionofmiltefosinesusceptibilityamongclinicalleishmaniadonovaniisolatesoftheindiansubcontinentexhibitingresistancetomultipledrugs |